243 related articles for article (PubMed ID: 20971709)
1. Onchocerciasis in Anambra State, Southeast Nigeria: clinical and psychological aspects and sustainability of community directed treatment with ivermectin (CDTI).
Mbanefo EC; Eneanya CI; Nwaorgu OC; Oguoma VM; Otiji MO; Ogolo BA
Postgrad Med J; 2010 Oct; 86(1020):573-7. PubMed ID: 20971709
[TBL] [Abstract][Full Text] [Related]
2. The African Programme for Onchocerciasis Control: impact on onchocercal skin disease.
Ozoh GA; Murdoch ME; Bissek AC; Hagan M; Ogbuagu K; Shamad M; Braide EI; Boussinesq M; Noma MM; Murdoch IE; Sékétéli A; Amazigo UV
Trop Med Int Health; 2011 Jul; 16(7):875-83. PubMed ID: 21481109
[TBL] [Abstract][Full Text] [Related]
3. Onchocerciasis in Anambra State, Southeast Nigeria: endemicity and clinical manifestations.
Mbanefo EC; Eneanya CI; Nwaorgu OC; Otiji MO; Oguoma VM; Ogolo BA
Postgrad Med J; 2010 Oct; 86(1020):578-83. PubMed ID: 20702432
[TBL] [Abstract][Full Text] [Related]
4. Influence of health education on community participation in rapid assessment of onchocerciasis prior to distribution of ivermectin.
Shu EN; Nwadike KI; Onwujekwe EO; Ugwu OC; Okonkwo PO
East Afr Med J; 1999 Jun; 76(6):320-3. PubMed ID: 10750518
[TBL] [Abstract][Full Text] [Related]
5. Traditional kinship system enhanced classic community-directed treatment with ivermectin (CDTI) for onchocerciasis control in Uganda.
Katabarwa MN; Habomugisha P; Agunyo S; McKelvey AC; Ogweng N; Kwebiiha S; Byenume F; Male B; McFarland D
Trans R Soc Trop Med Hyg; 2010 Apr; 104(4):265-72. PubMed ID: 20106493
[TBL] [Abstract][Full Text] [Related]
6. Implementing community-directed treatment with ivermectin for the control of onchocerciasis in Uganda (1997-2000): an evaluation.
Katabarwa MN; Habomugisha P; Richards FO
Ann Trop Med Parasitol; 2002 Jan; 96(1):61-73. PubMed ID: 11998803
[TBL] [Abstract][Full Text] [Related]
7. Involvement of women in community-directed treatment with ivermectin for the control of onchocerciasis in Rukungiri district, Uganda: a knowledge, attitude and practice study.
Katabarwa MN; Habomugisha P; Ndyomugyenyi R; Agunyo S
Ann Trop Med Parasitol; 2001 Jul; 95(5):485-94. PubMed ID: 11487370
[TBL] [Abstract][Full Text] [Related]
8. Changes in stigma and discrimination of onchocerciasis in Africa.
Tchounkeu YF; Onyeneho NG; Wanji S; Kabali AT; Manianga C; Amazigo UV; Amuyunzu-Nyamongo M
Trans R Soc Trop Med Hyg; 2012 Jun; 106(6):340-7. PubMed ID: 22513165
[TBL] [Abstract][Full Text] [Related]
9. Audit of the community-directed treatment with ivermectin (CDTI) for onchocerciasis and factors associated with adherence in three regions of Cameroon.
Kamga GR; Dissak-Delon FN; Nana-Djeunga HC; Biholong BD; Ghogomu SM; Souopgui J; Kamgno J; Robert A
Parasit Vectors; 2018 Jun; 11(1):356. PubMed ID: 29921312
[TBL] [Abstract][Full Text] [Related]
10. Additional health and development activities for community-directed distributors of ivermectin: threat or opportunity for onchocerciasis control?
Okeibunor JC; Ogungbemi MK; Sama M; Gbeleou SC; Oyene U; Remme JH
Trop Med Int Health; 2004 Aug; 9(8):887-96. PubMed ID: 15303994
[TBL] [Abstract][Full Text] [Related]
11. Community-directed health (CDH) workers enhance the performance and sustainability of CDH programmes: experience from ivermectin distribution in Uganda.
Katabarwa MN; Richards FO
Ann Trop Med Parasitol; 2001 Apr; 95(3):275-86. PubMed ID: 11339887
[TBL] [Abstract][Full Text] [Related]
12. Community response to repeated annual ivermectin treatment of onchocerciasis in Nigeria.
Oyibo WA; Fagbenro-Beyioku AF
Parasitol Res; 2002 Jul; 88(7):704-7. PubMed ID: 12107465
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with coverage in community-directed treatment with ivermectin for onchocerciasis control in Oyo State, Nigeria.
Brieger WR; Otusanya SA; Oke GA; Oshiname FO; Adeniyi JD
Trop Med Int Health; 2002 Jan; 7(1):11-8. PubMed ID: 11851950
[TBL] [Abstract][Full Text] [Related]
14. Factors affecting the attrition of community-directed distributors of ivermectin, in an onchocerciasis-control programme in the Imo and Abia states of south-eastern Nigeria.
Emukah EC; Enyinnaya U; Olaniran NS; Akpan EA; Hopkins DR; Miri ES; Amazigo U; Okoronkwo C; Stanley A; Rakers L; Richards FO; Katabarwa MN
Ann Trop Med Parasitol; 2008 Jan; 102(1):45-51. PubMed ID: 18186977
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the performance of community-directed treatment with ivermectin strategy for the control and elimination of onchocerciasis in Edo State, Nigeria.
Onowhakpor AO; Okojie OH; Wagbatsoma VA
Indian J Public Health; 2017; 61(4):267-273. PubMed ID: 29219132
[TBL] [Abstract][Full Text] [Related]
16. Control of onchocerciasis.
Boatin BA; Richards FO
Adv Parasitol; 2006; 61():349-94. PubMed ID: 16735169
[TBL] [Abstract][Full Text] [Related]
17. Monitoring ivermectin distributors involved in integrated health care services through community-directed interventions--a comparison of Cameroon and Uganda experiences over a period of three years (2004-2006).
Katabarwa M; Habomugisha P; Eyamba A; Agunyo S; Mentou C
Trop Med Int Health; 2010 Feb; 15(2):216-23. PubMed ID: 20002616
[TBL] [Abstract][Full Text] [Related]
18. The community-based treatment of onchocerciasis in Shao, Kwara State, Nigeria.
Oyibo WA; Fagenro-Beyioku AF
Southeast Asian J Trop Med Public Health; 2002 Sep; 33(3):496-503. PubMed ID: 12693582
[TBL] [Abstract][Full Text] [Related]
19. A model for evaluating the sustainability of community-directed treatment with ivermectin in the African Program for Onchocerciasis Control.
Okeibunor J; Bump J; Zouré HG; Sékétéli A; Godin C; Amazigo UV
Int J Health Plann Manage; 2012; 27(3):257-71. PubMed ID: 22711222
[TBL] [Abstract][Full Text] [Related]
20. Endemicity of onchocerciasis in some local government areas of Niger state.
Idowu ET; Adewale B; Mafe MA; Appelt B; Bamgbose A
Afr J Med Med Sci; 2004 Mar; 33(1):31-4. PubMed ID: 15490791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
